| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.3B | $15.7B | $14.7B | $14.3B | $14.3B | $13.2B | $4.1B | $4.1B |
| Cost of Revenue | $15.8B | $12.8B | $12.0B | $11.6B | $11.5B | $11.0B | $12.2B | $12.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.7B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.5B |
| Operating Income | $0.4B | $2.3B | $2.1B | $2.1B | $2.2B | $1.6B | $0.6B | $0.6B |
| Net Income | $-0.1B | $1.5B | $1.4B | $1.3B | $1.4B | $0.9B | $0.4B | $0.4B |
| EPS (Basic) | $-0.27 | $7.54 | $6.98 | $6.40 | $6.57 | $4.38 | $1.90 | $1.78 |
| EPS (Diluted) | $-0.27 | $7.46 | $6.91 | $6.36 | $6.53 | $4.37 | $1.89 | $1.77 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $54.4B | $29.6B | $28.0B | $27.0B | $28.4B | $27.6B | $26.8B | $24.6B |
| Current Assets | $27.5B | $16.2B | $15.4B | $14.6B | $15.9B | $15.6B | $14.6B | $13.7B |
| Cash & Equivalents | — | — | — | — | $5.3B | $5.6B | $4.3B | $3.7B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $29.5B | $16.3B | $16.2B | $15.1B | $16.2B | $15.5B | $16.0B | $15.3B |
| Stockholders' Equity | $12.0B | $4.2B | $3.6B | $3.3B | $3.3B | $3.1B | $2.9B | $2.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.9B | $1.7B | $1.4B | $0.9B | $1.9B | $1.7B | $1.9B | $1.7B |
| Investing Cash Flow | $1.0B | $-1.1B | $0.1B | $-0.4B | $-0.7B | $-0.1B | $-0.0B | $-0.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.7B | $0.1B | $0.1B | $0.2B |
| Financing Cash Flow | $-1.6B | $-0.6B | $-1.4B | $-1.4B | $-1.4B | $-0.4B | $-1.2B | $-1.4B |